HXP-056

N/A

Report date: 2025/01/08 14:53:46
NME

Base Information

Drug NameHXP-056
Drug Alias NameHXP056HXP-056
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedemaSolid tumoursRetinal Vein Occlusion +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFujian Haixi Pharmaceuticals Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesFujian Haixi Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaSolid tumoursRetinal Vein Occlusion +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A